Individuals with hematologic malignancies enroll in hospice care less than patients with other cancers, and lack of access to blood transfusions is likely a key reason why.New survey data indicate ...

European doctors came to Medscape Medical News to read about everything from GLP-1s to digital healthcare tools, in addition ...

Inflammation covertly rewires the bone marrow, enabling mutated stem cells to rise and setting the stage for future blood disease.

For patients with blood cancer, it is crucial to own their own cancer journey, as a five-time cancer survivor and author ...

Caribou plans a pivotal Phase 3 randomized trial evaluating approximately 250 patients in second-line large B-cell lymphoma. The FDA granted vispa-cel Regenerative Medicine Advanced Therapy, Orphan ...

Due to the extremely rare overlap of mitochondrial DNA depletion syndrome type 3 and pediatric hepatocellular carcinoma, the case presents daunting therapeutic challenges.

Market forecasters project the CAR-T cell therapy market will surge from $3.87 billion in 2024 to $13.25 billion by 2030, driven by unprecedented efficacy in relapsed and refractory patient ...

A national prospective study has confirmed a long-suspected link between Agent Orange and a rare but serious form of blood ...

Danielle Fishel shared that following the completion of her breast cancer treatment, she's feeling healthy and positive ...

The mortality-to-incidence ratio initially increased in the early 2000s, declined sharply between 2008 and 2011, and remained stable thereafter.

"There remains an urgent need for novel therapies for patients with BRCA2-mutated mCSPC, who face significantly faster disease progression and often shorter survival compared to those without the ...